Reviewing AACC 2023: Seamaty's In-Vitro Diagnostic Products Take Center Stage

July 25-27 2023, at the most significant international academic conference in the field of clinical diagnostics, the AACC Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, USA, Seamaty, a high-tech enterprise, showcased its independently developed and outstanding product series, injecting new vitality into the advancement of clinical laboratory science.

The AACC has consistently aimed to enhance the technical expertise of clinical laboratory professionals worldwide and drive progress in clinical laboratory science. This year's conference, which took place from July 25th to 27th, attracted over 20,000 international medical professionals from 110 countries.

As a leading company specializing in the research, production, and sales of Point-of-Care Testing (POCT) products, Seamaty presented its latest product series at the exhibition, including fully automated biochemistry analyzers, semi-automated chemical analyzers, blood gas & electrolyte analyzers, hematology analyzers, fully automated veterinary biochemistry analyzers.

Seamaty's booth, numbered 4257, became one of the most eye-catching highlights of this year's AACC Annual Meeting. Seamaty’s product series not only achieved groundbreaking technological advancements but also addressed the wide range of challenging health issues in diagnostic research and technology. Attendees had the opportunity to learn about and experience these cutting-edge technologies and establish connections with global leaders in clinical chemistry, molecular diagnostics, laboratory management, and other related fields.

Seamaty's outstanding performance showcased its leading position in the field of in-vitro diagnostics, attracting considerable attention from numerous industry professionals. Not only did Seamaty demonstrate the advanced features and high quality of their products, but through professional demonstrations and interactions, Seamaty also conveyed the significance of the field's major changes and technological innovations.

AACC serves as a global platform for communication and collaboration in the clinical diagnostics field, and Seamaty's active participation and showcase of our exceptional products further reinforced Seamaty’s international influence and reputation.

About Seamaty:

Seamaty is a high-tech enterprise specializing in Point-of-Care Testing (POCT) products. Over the years, Seamaty has constructed five major technology platforms, including biochemistry, blood gas, immunology, hematology, and molecular, providing comprehensive solutions for clinical laboratories. The company has established research centers in Chengdu and Shenzhen, continuously contributing to technological innovation in the field of in-vitro diagnostics. Moreover, Seamaty has set up overseas subsidiaries in countries such as Germany, Russia, and Thailand, expanding our global market presence.

During this AACC Annual Meeting, Chengdu Seamaty Technology showcased our latest product series, including biochemistry, blood gas, immunology, hematology, and molecular platforms. Seamaty's participation enriched the conference, highlighting the company's leading position and technological achievements in the field of in-vitro diagnostics.

Looking ahead, Chengdu Seamaty Technology will persist in technological innovation, continuously enhance product quality and technical capabilities, and contribute our efforts to providing more advanced and reliable diagnostic solutions for clinical laboratory professionals and patients, thus advancing the global healthcare industry.

▼Click to watch the exciting moments at the exhibition site ▼